Powered by

TransEnterix Announces the Senhance(TM) Expansion into Robotic Hernia Repair

Mar 22, 2017 - Business Wire

TransEnterix, Inc. (NYSE MKT: TRXC) ("TransEnterix"), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that it has expanded the clinical adoption of the Senhance Robotic Surgical System ("the Senhance") to include a full range of hernia repair surgeries.

Hernia repairs represent one of the largest procedural opportunities for the Senhance. Millennium Research Group has estimated that during 2017, there will be a total of...